Coloplast A/S (OTCMKTS:CLPBY) Sees Strong Trading Volume – Time to Buy?

Shares of Coloplast A/S Sponsored ADR (OTCMKTS:CLPBY) saw unusually-high trading volume on Monday . Approximately 847,664 shares changed hands during trading, an increase of 47% from the previous session’s volume of 575,459 shares.The stock last traded at $6.36 and had previously closed at $6.30.

Analyst Ratings Changes

A number of analysts recently weighed in on the stock. The Goldman Sachs Group cut shares of Coloplast A/S from a “hold” rating to a “strong sell” rating in a report on Tuesday, April 7th. Sanford C. Bernstein upgraded shares of Coloplast A/S to a “hold” rating in a report on Wednesday, January 28th. One investment analyst has rated the stock with a Hold rating and one has given a Sell rating to the company’s stock. Based on data from MarketBeat.com, Coloplast A/S presently has an average rating of “Reduce”.

Coloplast A/S Stock Up 0.5%

The stock has a market capitalization of $14.27 billion, a P/E ratio of 23.45, a PEG ratio of 2.03 and a beta of 0.15. The company has a debt-to-equity ratio of 1.50, a current ratio of 1.30 and a quick ratio of 0.81. The stock’s fifty day moving average is $6.81 and its two-hundred day moving average is $8.04.

Coloplast A/S (OTCMKTS:CLPBY) last issued its earnings results on Friday, February 6th. The company reported $0.10 earnings per share for the quarter, topping analysts’ consensus estimates of $0.09 by $0.01. The firm had revenue of $1.11 billion during the quarter, compared to analysts’ expectations of $1.12 billion. Coloplast A/S had a net margin of 14.35% and a return on equity of 27.87%. As a group, research analysts predict that Coloplast A/S Sponsored ADR will post 0.39 earnings per share for the current fiscal year.

About Coloplast A/S

Coloplast A/S is a global developer and manufacturer of medical devices and services focused on intimate healthcare. The company specializes in solutions designed to assist individuals with chronic medical conditions, aiming to improve quality of life through innovative products. Coloplast’s offerings span ostomy care, continence care, wound and skin care, and interventional urology, targeting patients who require long-term support and specialized treatments.

In its ostomy business, Coloplast provides pouches, skin barriers and accessories for patients who have had surgical procedures to divert bodily waste.